BioMarker Services

ValiFinn performs all its biomarker measurement services according to the ISO/IEC 17025 quality assurance system (see http://www.isoiec17025.com/home.html for further information). This allows performing services for the pharma industry for clinical trials, which is also important for the parent company Valirx Plc who will perform all clinical biomarker measurements for their clinical trials in ValiFinn.

Pharmaceutical industry, academic research groups and hospitals can outsource their biomarker measurements to ValiFinn for both preclinical and clinical sample panels. ValiFinn offers a wide range of biomarker measurement services using commercially available methods from companies such as Immunodiagnostic Systems (IDS), Merck Millipore, PromoKine and Fujirebio. Please check through the links below for details about some biomarker measurements that we offer.

– IDS http://www.idsplc.com/
– Merck Millipore http://www.millipore.com/bmia/flx4/biomarkers-immunoassays-homepage
– PromoKine http://www.promokine.info/products/antibodies-elisa-kits/elisa-kits/
– Fujirebio http://www.fdab.com/world_home/products/products.html

Services of ValiFinn also include development of biomarker methods. Staff of ValiFinn has long experience in developing novel biomarker methods, and several methods that they have developed are currently commercially available as diagnostic kits. The parent company Valirx Plc will utilize this experience by developing companion diagnostics for the novel cancer therapies that they are currently developing, and the experience is also available for other pharma companies and diagnostic companies as service.

The services for consumers include biomarker measurements for health monitoring (vitamin D, cholesterol, glucose, thyroid markers etc). These services are currently offered for local consumers in the Oulu region and in other cities in Northern Finland, and the concept will be multiplied to outside Finland.

Finland Information on ValiFinn:- Please visit http://www.valifinn.com for all the current clinical biomarker and diagnostic services offered.